Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001323874 | SCV001514809 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004978325 | SCV005569433 | uncertain significance | Inborn genetic diseases | 2024-09-09 | criteria provided, single submitter | clinical testing | The c.1402C>T (p.R468C) alteration is located in exon 11 (coding exon 11) of the COL7A1 gene. This alteration results from a C to T substitution at nucleotide position 1402, causing the arginine (R) at amino acid position 468 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001830982 | SCV002079300 | uncertain significance | Epidermolysis bullosa dystrophica | 2020-04-14 | no assertion criteria provided | clinical testing |